Analysis of direct, indirect, and intangible costs of epilepsy by A. Pato Pato, E. Cebrián Pérez, I. Cimas Hernando, J.R. Lorenzo González, I. Rodríguez Constenla, F. Gude Sampedro

Get full text

Análisis de costes directos, indirectos e intangibles de la epilepsia by A. Pato Pato, E. Cebrián Pérez, I. Cimas Hernando, J.R. Lorenzo González, I. Rodríguez Constenla, F. Gude Sampedro

Get full text

Adaptación cultural y validación al español de España del MSTCQ© (Multiple Sclerosis Treatment Concerns Questionnaire) by E. Muntéis Olivas, G. Navarro Mascarell, J. Meca Lallana, A. Maestre Martínez, Á. Pérez Sempere, J. Gracia Gil, A. Pato Pato

Get full text

Cultural adaptation and validation of a peninsular Spanish version of the MSTCQ© (Multiple Sclerosis Treatment Concerns Questionnaire) by E. Muntéis Olivas, G. Navarro Mascarell, J. Meca Lallana, A. Maestre Martínez, Á. Pérez Sempere, J. Gracia Gil, A. Pato Pato

Get full text

Progression of a series of patients with relapsing-remitting multiple sclerosis treated for 7 years with natalizumab using the “no evidence of disease activity” parameter by A. Pato Pato, E. Costa Arpín, A. Rodríguez Regal, I. Rodríguez Constenla, I. Cimas Hernando, I. Muñoz Pousa, L. Naya Ríos, J.R. Lorenzo González, M.C. Amigo Jorrín, J.M. Prieto González

Get full text